Zhengye Biotechnology Holding Limited (ZYBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 12-2023 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -3,565 | 1,846 | 1,475 | 5,161 |
| Depreciation Amortization | 1,710 | 3,310 | 1,551 | 3,290 |
| Income taxes - deferred | -745 | N/A | N/A | N/A |
| Accounts receivable | 3,258 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -211 | N/A | N/A | N/A |
| Other Working Capital | 61 | -134 | -264 | -2,820 |
| Other Operating Activity | -2,457 | 602 | -740 | 999 |
| Operating Cash Flow | $-1,949 | $5,624 | $2,022 | $6,630 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -36 | -1,847 | -242 | -872 |
| Purchase Sale Intangibles | -57 | N/A | N/A | N/A |
| Other Investing Activity | -57 | -1,943 | -1,936 | -746 |
| Investing Cash Flow | $-93 | $-3,790 | $-2,178 | $-1,618 |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 5,850 | N/A | N/A | N/A |
| Common Stock Issued | 6,219 | N/A | N/A | N/A |
| Dividend Paid | N/A | -2,195 | -2,182 | -5,429 |
| Other Financing Activity | -6,162 | -836 | -413 | 2,817 |
| Financing Cash Flow | $5,907 | $-3,031 | $-2,595 | $-2,612 |
| Exchange Rate Effect | -96 | 22 | N/A | 0 |
| Beginning Cash Position | 2,597 | 3,724 | 3,741 | 1,341 |
| End Cash Position | 6,366 | 2,549 | 990 | 3,741 |
| Net Cash Flow | $3,769 | $-1,175 | $-2,751 | $2,400 |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,949 | 5,624 | 2,022 | 6,630 |
| Capital Expenditure | -36 | N/A | N/A | N/A |
| Free Cash Flow | -1,985 | 5,624 | 2,022 | 6,630 |